Yh. Yang et Ja. Hamilton, Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor, ARTH RHEUM, 44(1), 2001, pp. 111-119
Objective, To determine whether granulocyte-macrophage colony-stimulating f
actor (GM-CSF) and macrophage CSF (M-CSF or CSF-1) are involved in the meth
ylated bovine serum albumin/interleukin-1 (mBSA/IL-1)-induced arthritis mod
el.
Methods. Following systemic injection, IL-1 has been shown to augment a wea
k inflammatory response to mBSA in murine joints and to induce an acute ero
sive arthritis. GM-CSF and M-CSF have been implicated in inflammatory react
ions, including those in joints, and have recently been shown to exacerbate
murine arthritis, Since in vitro studies have found that IL-1 can enhance
GM-CSF and M-CSF production, we reasoned that they might be playing a part
in IL-1-mediated arthritis. GM-CSF-deficient (GM-CSF-/-) and M-CSF-deficien
t (op/op) mice were injected intraarticularly with mBSA and subcutaneously
with IL-1, Arthritis was monitored histologically on day 7, Normal mice wer
e also treated intraperitoneally with blocking monoclonal antibodies to GM-
CSF and M-CSF, and to the M-CSF receptor. Numbers of macrophages (Mac-2 and
F4/80 staining) were monitored, as was the number of cycling (bromodeoxyur
idine-positive) cells.
Results, GM-CSF-/- mice and normal mice treated with anti-GM-CSF antibody d
id not show IL-1-induced arthritis progression. There was a dramatic reduct
ion in synovial cellularity, including reduced numbers of macrophages and c
ycling cells, The op/op mice did not develop mBSA/IL-1-induced disease, but
blocking antibody to M-CSF or to the M-CSF receptor failed to diminish dis
ease in normal mice.
Conclusion. GM-CSF is involved in the IL-1-induced arthritis that follows m
BSA injection; M-CSF involvement in the model is also suggested, since op/o
p mice did not develop arthritis. These studies provide the first in vivo e
vidence for a role of GM-CSF, and possibly M-CSF, in the proinflammatory ac
tions of IL-1.